12-103841009-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001031701.3(NT5DC3):c.148G>A(p.Ala50Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000123 in 1,304,684 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001031701.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NT5DC3 | NM_001031701.3 | c.148G>A | p.Ala50Thr | missense_variant | 1/14 | ENST00000392876.8 | NP_001026871.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NT5DC3 | ENST00000392876.8 | c.148G>A | p.Ala50Thr | missense_variant | 1/14 | 1 | NM_001031701.3 | ENSP00000376615.3 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152004Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000868 AC: 10AN: 1152680Hom.: 0 Cov.: 30 AF XY: 0.0000144 AC XY: 8AN XY: 555262
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152004Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74240
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 10, 2024 | The c.148G>A (p.A50T) alteration is located in exon 1 (coding exon 1) of the NT5DC3 gene. This alteration results from a G to A substitution at nucleotide position 148, causing the alanine (A) at amino acid position 50 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at